| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103113382A Group of sesquiterpenoid coumarin and sesquiterpenoid chromone compounds |
| 05/22/2013 | CN103113349A 4-imidazolyl quinoline and quinazoline ketone aromatizing enzyme inhibitors as well as preparation method and medical application thereof |
| 05/22/2013 | CN103110956A Method for preparing glucose-responsive insulin-self-regulating-release carrier |
| 05/22/2013 | CN103110933A Elcatonin composition and preparation method thereof |
| 05/22/2013 | CN103110590A Cymipristone solid preparation and preparation method thereof |
| 05/22/2013 | CN102100684B Application of secoisolariciresinol in preparation of medicament for treating depression and anxiety |
| 05/21/2013 | US8445470 Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
| 05/21/2013 | US8443799 Dry powder inhalation system for transpulmonary administration |
| 05/21/2013 | CA2518541C Gonadal function improving agents |
| 05/21/2013 | CA2459869C A system for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer |
| 05/16/2013 | WO2013071262A1 Calcimimetics and methods for their use |
| 05/16/2013 | WO2013070660A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/16/2013 | CA2854911A1 Calcimimetics and methods for their use |
| 05/16/2013 | CA2854836A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/15/2013 | EP2590652A1 Pharmaceutical compositions containing vanoxerine |
| 05/15/2013 | CN103102383A Crystal form A of glycyrrhetinic acid-30-amide derivative and preparation method thereof |
| 05/15/2013 | CN103102382A Crystal form B of glycyrrhetinic acid-30-amide derivative and preparation method thereof |
| 05/15/2013 | CN103099902A Traditional Chinese medicine composition for treating subacute thyroiditis and preparation method thereof |
| 05/15/2013 | CN102366412B Preparation method of tolvaptan tablet |
| 05/15/2013 | CN102336801B Abiraterone acetate polymorphic substance and pharmaceutical composition |
| 05/15/2013 | CN102160889B Extract, composition, and use of overground part of hedychium coronarium koenig |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440628 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 05/14/2013 | CA2655959C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 05/14/2013 | CA2560927C Insulin resistance-improving agent |
| 05/10/2013 | WO2013067163A1 Neprilysin inhibitors |
| 05/10/2013 | WO2013065763A1 Method for culturing stem cell |
| 05/10/2013 | WO2013064620A1 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17β-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis |
| 05/10/2013 | CA2854215A1 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17.beta.-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis |
| 05/10/2013 | CA2853671A1 Medical use |
| 05/10/2013 | CA2850953A1 Neprilysin inhibitors |
| 05/08/2013 | EP2589383A1 FKBP subtype-specific rapamycin analogue for use in treatment of diseases |
| 05/08/2013 | EP2588445A1 New polymorphic form of a calcimimetic compound |
| 05/08/2013 | EP2588444A1 New polymorphic form of a calcimimetic compound |
| 05/08/2013 | CN103087140A Preparation method of ulipristal acetate polycrystal |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103083509A Preparation method for traditional Chinese medicine prescription capable of treating anterior hypopituitarism |
| 05/08/2013 | CN103083231A Fulvestrant containing oil needle preparation |
| 05/08/2013 | CN102274390B Medicinal composition for high-androgen polycystic ovary syndrome |
| 05/08/2013 | CN102020638B 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 05/08/2013 | CN101574084B 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | US8436136 Peptide complex |
| 05/07/2013 | US8435975 Steroidal esters of 17-oximino-5-androsten-3beta-ol |
| 05/07/2013 | US8435944 Method and composition for transdermal drug delivery |
| 05/07/2013 | US8435561 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 05/07/2013 | CA2397030C Methods for treating pancreatic disorders |
| 05/02/2013 | WO2013063046A1 Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors |
| 05/02/2013 | US20130109697 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 05/02/2013 | US20130108694 Dry blend formulation of tetrahydrobiopterin |
| 05/01/2013 | EP2585482A1 Glucagon analogues |
| 05/01/2013 | EP2585435A1 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments |
| 05/01/2013 | CN103080080A 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments |
| 05/01/2013 | CN103073450A Solid forms of selective androgen receptor modulators |
| 05/01/2013 | CN103070879A Application of hyperin in preparing anti-ovarian-senescence drug |
| 05/01/2013 | CN103070849A Application of oxyresveratrol in preparing ovary aging resistant medicine |
| 05/01/2013 | CN103070828A Solid dispersion and tablets comprising abiraterone acetate, and preparation methods thereof |
| 05/01/2013 | CN102643255B Andrographolide compound |
| 05/01/2013 | CN102397275B Aromatization enzyme inhibitor |
| 05/01/2013 | CN102286064B Compound with insulin-sensitizing activity as well as preparation method and application thereof |
| 05/01/2013 | CN102283256B Star anise extract for killing Meloidogyne spp. and preparation method thereof |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431557 Treatment of menopause-associated symptoms |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | CA2582180C Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents |
| 04/25/2013 | WO2013058361A1 Crystals of androgen receptor antagonist compound |
| 04/25/2013 | WO2013057372A1 Novel non-steroidal compounds as androgen receptor modulators |
| 04/25/2013 | WO2013056547A1 Synthesis of a group of hydantoin derivatives and use thereof |
| 04/25/2013 | US20130102690 Collagen-polysaccharide materials mimicking blood vessels, tissues and bones for medical, pharmaceutical and orthopedic applications, and processes for producing the same |
| 04/25/2013 | US20130102073 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130098357 Cerivastatin to treat pulmonary disorders |
| 04/25/2013 | CA2852939A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| 04/25/2013 | CA2852937A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| 04/25/2013 | CA2852936A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| 04/25/2013 | CA2852468A1 Peptidomimetic macrocyles |
| 04/24/2013 | EP2582713A1 (11 beta,17 alpha)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one |
| 04/24/2013 | EP2582681A1 Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/24/2013 | EP2582680A1 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/24/2013 | EP2582674A1 Gpr120 receptor agonists and uses thereof |
| 04/24/2013 | EP2582371A1 Methods of treating or preventing estrogen-related diseases |
| 04/24/2013 | CN1535141B Sustained-release composition and process for producing the same |
| 04/24/2013 | CN103068841A 胰高血糖素类似物 Glucagon analogs |
| 04/24/2013 | CN103068400A Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 04/24/2013 | CN103058832A Application of selective estrogen receptor modulator |
| 04/24/2013 | CN103055314A 雌激素的应用 Application of estrogen |
| 04/24/2013 | CN103055084A Flowery flavour menstruation inducing piece |
| 04/24/2013 | CN103054903A Adult sertoli cell-pancreas islet compound and preparation method for same |
| 04/24/2013 | CN102526315B Preparation method of extracts of effective fractions of lychee seeds |
| 04/24/2013 | CN102319267B Method for efficiently preparing bee pollen aqueous extract |
| 04/24/2013 | CN102145041B Pharmaceutical composition with function of treating polycystic ovary syndrome |
| 04/24/2013 | CN101823975B Method for industrially producing L-tyrosine by using poultry feather as raw materials |
| 04/24/2013 | CN101815535B Molecules for targeting compounds to various selected organs or tissues |
| 04/24/2013 | CN101597321B LHRH antagonist with long-acting low-histamine release side effect |
| 04/24/2013 | CN101072551B Sustained release formulation comprising bisphosphonate |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |